Impact BioMedical, Inc. (IBO)
3.55
-0.18
(-4.83%)
USD |
NYAM |
Oct 27, 16:00
3.50
-0.05
(-1.41%)
After-Hours: 20:00
Impact BioMedical Price to Book Value : 2.817 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 2.817 |
| October 26, 2026 | 2.960 |
| October 23, 2026 | 2.857 |
| October 22, 2026 | 3.016 |
| October 21, 2026 | 3.190 |
| October 20, 2026 | 2.593 |
| October 19, 2026 | 2.428 |
| October 16, 2026 | 2.127 |
| October 15, 2026 | 2.506 |
| October 14, 2026 | 2.701 |
| October 13, 2026 | 3.158 |
| October 12, 2026 | 3.198 |
| October 09, 2026 | 3.373 |
| October 08, 2026 | 3.262 |
| October 07, 2026 | 3.555 |
| October 06, 2026 | 3.714 |
| October 05, 2026 | 3.841 |
| October 02, 2026 | 4.222 |
| October 01, 2026 | 4.309 |
| September 30, 2026 | 4.444 |
| September 29, 2026 | 4.444 |
| September 28, 2026 | 4.452 |
| September 25, 2026 | 4.516 |
| September 24, 2026 | 4.484 |
| September 23, 2026 | 5.261 |
| Date | Value |
|---|---|
| September 22, 2026 | 5.284 |
| September 21, 2026 | 5.565 |
| September 18, 2026 | 5.909 |
| September 17, 2026 | 5.723 |
| September 16, 2026 | 4.988 |
| September 15, 2026 | 5.298 |
| September 14, 2026 | 4.848 |
| September 11, 2026 | 4.609 |
| September 10, 2026 | 4.417 |
| September 09, 2026 | 4.944 |
| September 08, 2026 | 5.008 |
| September 04, 2026 | 5.408 |
| September 03, 2026 | 4.807 |
| September 02, 2026 | 4.907 |
| September 01, 2026 | 4.587 |
| August 31, 2026 | 4.618 |
| August 28, 2026 | 4.444 |
| August 27, 2026 | 4.417 |
| August 26, 2026 | 4.408 |
| August 25, 2026 | 4.609 |
| August 24, 2026 | 4.537 |
| August 21, 2026 | 4.807 |
| August 20, 2026 | 4.500 |
| August 19, 2026 | 4.338 |
| August 18, 2026 | 4.707 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LENZ Therapeutics, Inc. | 0.4513 |
| Enveric Biosciences, Inc. | 0.6915 |
| ANI Pharmaceuticals, Inc. | 2.738 |
| Corcept Therapeutics, Inc. | 13.39 |
| Veru, Inc. | 1.37 |
Price to Book Value Related Metrics
| PS Ratio | 667.91 |
| Price | 3.55 |
| Earnings Yield | -34.92% |
| Market Cap | 30.33M |